Xoma
Link ID 246376
Title Xoma
Url http://www.xoma.com/
Description Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
Category Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
Keywords
Date Jul 19, 2006
Contact Name
Email
Add to My Favorite   Refer it to Friend   Report Broken Link  


 Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development
1. Trophogen, Inc
  Development of superactive hormones and growth factors for therapeutic applications. Based in Rockville, Maryland, USA.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


2. Genfit
  Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research headquartered in Loos, France.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


3. Intrabiotics Pharmaceuticals, Inc.
  Develops antibacterial and antifungal drugs, including protegrins and related antimicrobial peptides, for application in cystic fibrosis. Includes pipeline, publications, and investor information from Palo Alto, California. (Nasdaq: IBPI)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


4. Aphton Corp.
  Develops products using vaccine-like technology for neutralizing hormones which participate in gastrointestinal system and reproductive system cancer and non-cancer diseases and the prevention of pregnancy. Based in Miami, Florida. (Nasdaq: APHT)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development


5. Xoma
  Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development




Home      New Listings      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing     Disclaimer
Copyright © internet-directory.com 1999-2023

Sponsors